Contrast induced nephropathy after angiography

American Journal of the Medical Sciences

Volumn 323, Issue 5, 2002, Pages 252-258

  Stouffer, George A ^a   Sheahan, Richard G ^a   Lenihan, Daniel J ^a   Agrawal, Malay ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

3 (2 CARBOXYMETHOXY 4 METHOXYPHENYL) 1 (3,4 METHYLENEDIOXYPHENYL) 5 PROPOXY 2 INDANCARBOXYLIC ACID; ACETYLCYSTEINE; AMINOPHYLLINE; ATRIAL NATRIURETIC FACTOR; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; DOPAMINE; ENDOTHELIN RECEPTOR ANTAGONIST; FUROSEMIDE; IONIC CONTRAST MEDIUM; MANNITOL; NONIONIC CONTRAST MEDIUM; THEOPHYLLINE; ANTIOXIDANT; DIURETIC AGENT; ENDOTHELIN; VASODILATOR AGENT;

ANGIOCARDIOGRAPHY; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CREATININE CLEARANCE; DOSE RESPONSE; DRUG MECHANISM; HEART CATHETERIZATION; HUMAN; HYDRATION; INCIDENCE; KIDNEY FUNCTION; KIDNEY ISCHEMIA; NEPHROTOXICITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PREVENTION; RISK FACTOR; ACUTE KIDNEY FAILURE; ANIMAL; CHEMICALLY INDUCED DISORDER; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DRUG ANTAGONISM; FLUID THERAPY; METHODOLOGY; OSMOLARITY;

ANIMALS; ANTIOXIDANTS; CALCIUM CHANNEL BLOCKERS; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; DIURETICS; ENDOTHELINS; FLUID THERAPY; FUROSEMIDE; HUMANS; KIDNEY FAILURE, ACUTE; OSMOLAR CONCENTRATION; RISK FACTORS; VASODILATOR AGENTS;

EID: 0036083201     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000441-200205000-00004     Document Type: Article

References (39)

1. Contrast nephropathy
2. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy
3. Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents
4. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine
5. Captopril for prevention of contrast-induced nephropathy in diabetic patients: A randomized study
6. Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism
7. Incidence, risk factors, and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older
8. Contrast nephrotoxicity: A randomized controlled trial of a nonionic and an ionic radiographic contrast agent
9. Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency
10. Risk of radiocontrast nephropathy in patients with and without diabetes mellitus
11. Use of dopamine in prevention of contrast induced acute renal failure - A randomized study
12. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality
13. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency
14. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography
15. Nephrotoxicity of contrast media following cardiac angiography: Pathogenesis, clinical course, and preventive measures, including the role of low-osmolality contrast media
16. ACC/AHA guidelines for coronary angiography: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
17. Contrast-associated nephropathy: Presentation, pathophysiology, and management
18. Nephrotoxicity related to contrast media
19. Risks for renal dysfunction with cardiac angiography
20. American College of Cardiology/Society for Cardiac Angiography and Interventions Clinical Expert Consensus Document on cardiac catheterization laboratory standards. A report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents
21. Prophylaxis against contrast-induced nephropathy
22. Contrast nephropathy
23. Prehydration protects against contrast nephropathy in high risk patients undergoing cardiac catheterization
24. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
25. Pathophysiology of radiocontrast nephropathy: A role for medullary hypoxia
26. Prevention of contrast nephropathy after cardiac catheterisation
27. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease
28. Contrast nephropathy after coronary angioplasty in chronic renal insufficiency
29. Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media
30. A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy
31. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography
32. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: A prospective randomised clinical trial
33. Endothelin: What role in acute contrast nephropathy?
34. A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiography
35. Acetylycysteine to prevent angiography-related renal tissue injury (The APART Trial)
36. The role of mucomyst administration prior to percutaneous interventions on renal function in patients with chronic renal failure
37. Prevention of contrast-induced renal dysfunction with acetylcysteine in patients undergoing coronary angiography
38. Use of fenoldopam to prevent radiocontrast nephropathy in highrisk patients
39. Managing the high-risk patients: Experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention